Skip To Main Content

Fabry disease

Fabry disease is an X-linked lysosomal storage disease due to a defect in the gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A), causing progressive cellular accumulation of the substrate globotriaosylceramide (GL-3) and globo-triaosylsphingosine (lyso-GL-3).

Fabry disease is an X-linked lysosomal storage disease due to a defect in the gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A), causing progressive cellular accumulation of the substrate globotriaosylceramide (GL-3) and globo-triaosylsphingosine (lyso-GL-3).

This accumulation occurs in a variety of cell types and can lead to debilitating symptoms such as neurological pain, angiokeratoma, hypohidrosis in childhood, in girls usually a few years later than in boys. With age, progressive damage to the vital organs develops in both sexes that leads to organ failure. End-stage kidney disease and life-threatening cardiovascular or cerebrovascular complications limit life expectancy.

Although the disease is X-linked, most women develop symptoms. Fabry disease is pan-ethnic. Newborn screenings report frequencies of 1 in 22,570 men for the classic phenotype and of 1 in 1,390 men for the late-onset phenotype.1-3

Fabry-general-info

Suspect Fabry disease in case of..

Fabry symptomer

Test the patient, Test the family & Treat early

Family

Up to 5 family members may be diagnosed with Fabry disease for every index patient4

Lyssna på KardiologKvarten podcast

En podd med fokus på hypertrofisk kardiomyopati (HCM) och riktar sig till dig som möter patienter med HCM. Varje avsnitt är cirka 15 minuter långa.

Lyssna på KardiologKvarten här!

 

References

MAT-SE-2400586 v1.0 08/2024